Stakeholder Call - COVID-19 Vaccine for Adolescents

Stakeholder Call - COVID-19 Vaccine for Adolescents

Stakeholder Call - Myocarditis and Pericarditis Updates - 6/29/2021Подробнее

Stakeholder Call - Myocarditis and Pericarditis Updates - 6/29/2021

Stakeholder Call: COVID-19 Vaccine Update - 4/27/2021Подробнее

Stakeholder Call: COVID-19 Vaccine Update - 4/27/2021

CDC Stakeholder Call: Youth SportsПодробнее

CDC Stakeholder Call: Youth Sports

CDC Stakeholder Call: Camps and Youth ProgramsПодробнее

CDC Stakeholder Call: Camps and Youth Programs

Stakeholder Call: Preparing for the School Year: Younger Children & Adolescent Vaccine UpdatesПодробнее

Stakeholder Call: Preparing for the School Year: Younger Children & Adolescent Vaccine Updates

Stakeholder Call: COVID-19 Vaccine for Children 5-11 Years Old – 11/01/2021Подробнее

Stakeholder Call: COVID-19 Vaccine for Children 5-11 Years Old – 11/01/2021

Stakeholder Call: Pfizer-BioNTech COVID-19 Vaccine Booster Dose - 9/24/21Подробнее

Stakeholder Call: Pfizer-BioNTech COVID-19 Vaccine Booster Dose - 9/24/21

Stakeholder Call: COVID-19 TherapeuticsПодробнее

Stakeholder Call: COVID-19 Therapeutics

Stakeholder Call: COVID-19 Testing Update – 3/1/2021Подробнее

Stakeholder Call: COVID-19 Testing Update – 3/1/2021

Virtual Press Conference: COVID-19 Vaccine for Adolescents - 5/10/2021Подробнее

Virtual Press Conference: COVID-19 Vaccine for Adolescents - 5/10/2021

Adolescents Now Eligible for COVID-19 VaccinationПодробнее

Adolescents Now Eligible for COVID-19 Vaccination

Stakeholder Call - Guillain-Barré Syndrome (GBS), COVID-19 Vaccine Updates - 7/15/21Подробнее

Stakeholder Call - Guillain-Barré Syndrome (GBS), COVID-19 Vaccine Updates - 7/15/21

Concern Over Covid Vaccine In AdolescentsПодробнее

Concern Over Covid Vaccine In Adolescents

COVID-19 Vaccine for AdolescentsПодробнее

COVID-19 Vaccine for Adolescents

Pfizer's COVID-19 vaccine could soon be authorized for adolescentsПодробнее

Pfizer's COVID-19 vaccine could soon be authorized for adolescents

Director of FDA's CBER, Peter Marks, M.D., Ph.D. on COVID-19 Vaccine ConfidenceПодробнее

Director of FDA's CBER, Peter Marks, M.D., Ph.D. on COVID-19 Vaccine Confidence

FDA Authorizes Pfizer’s Covid-19 Vaccine for Adolescents Age 12 to 15Подробнее

FDA Authorizes Pfizer’s Covid-19 Vaccine for Adolescents Age 12 to 15

Novavax COVID-19 vaccine for teens 82% effectiveПодробнее

Novavax COVID-19 vaccine for teens 82% effective

School-Located Vaccination Strategies to Increase Child and Adolescent Immunization RatesПодробнее

School-Located Vaccination Strategies to Increase Child and Adolescent Immunization Rates

Актуальное